Cargando…

MARCH8 is associated with poor prognosis in non-small cell lung cancers patients

MARCH8 belongs to a family of membrane-associated RING-CH (MARCH) ubiquitin ligases. The functions of MARCH8 have been thoroughly investigated but its mechanism of action remains unknown. In this study, we detected the expression of MARCH8 protein in NSCLC samples and identified MARCH8 mRNA expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Jiye, Tian, Liying, Li, Manli, Huang, Shu-Hong, Zhang, Jing, Zhao, Baohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746139/ https://www.ncbi.nlm.nih.gov/pubmed/29296237 http://dx.doi.org/10.18632/oncotarget.22602

Ejemplares similares

Derlin-1 Promotes the Progression of Human Hepatocellular Carcinoma via the Activation of AKT Pathway
por: Fan, Jiye, et al.
Publicado: (2020)

Decreased expression of speckle-type POZ protein for the prediction of poor prognosis in patients with non-small cell lung cancer
por: Li, Jing-Jing, et al.
Publicado: (2017)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis
por: Wang, Zhao, et al.
Publicado: (2019)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer
por: Li, Qianping, et al.
Publicado: (2020)

Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients
por: Luo, Fan-Yan, et al.
Publicado: (2015)

High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis
por: He, Chaowen, et al.
Publicado: (2022)

High expression of Stabilin-2 predicts poor prognosis in non-small-cell lung cancer
por: Yong, Juanjuan, et al.
Publicado: (2021)

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
por: Tian, Yubin, et al.
Publicado: (2022)

High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer
por: Jiang, Chao, et al.
Publicado: (2018)

The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer
por: Liu, Xiang-hua, et al.
Publicado: (2013)

Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer
por: Fang, Luo, et al.
Publicado: (2017)

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer
por: Ma, Weijie, et al.
Publicado: (2023)

Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer
por: Liu, Dan, et al.
Publicado: (2017)

The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer
por: Huang, Hai-Tao, et al.
Publicado: (2020)

Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
por: Xu, Yu-Hua, et al.
Publicado: (2019)

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
por: Si, Jiahui, et al.
Publicado: (2017)

BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
por: Cao, Lili, et al.
Publicado: (2019)

SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Li, Jing, et al.
Publicado: (2020)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

Involvement of CHP2 in the Development of Non–Small Cell Lung Cancer and Patients’ Poor Prognosis
por: Xu, Liqin, et al.
Publicado: (2020)

Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
por: Cheng, Yuanjun, et al.
Publicado: (2020)

ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer
por: Jingushi, Kentaro, et al.
Publicado: (2021)

Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
por: Wang, Tao, et al.
Publicado: (2020)

GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
por: Feng, Yong, et al.
Publicado: (2022)

Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer
por: Kong, Peng-Zhou, et al.
Publicado: (2016)

Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy
por: Wang, Kaiyuan, et al.
Publicado: (2017)

High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy
por: Yang, Guang, et al.
Publicado: (2015)

LINK-A lncRNA is upregulated in metastatic non-small cell lung cancer and is associated with poor prognosis
por: Liu, Junqiang, et al.
Publicado: (2019)

Correction: BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

Topoisomerase I expression is associated with prognosis in postoperative non‐small cell lung cancer patients
por: Lu, Baohua, et al.
Publicado: (2016)

Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer
por: Wen, Qiuyuan, et al.
Publicado: (2015)

Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer
por: Fan, Chuifeng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a6br6vkkim08f9tpiibcqc1kvt